Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2695

1.

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?

Khan AA, Boriani G, Lip GYH.

Clin Res Cardiol. 2019 Sep 14. doi: 10.1007/s00392-019-01545-4. [Epub ahead of print] Review.

PMID:
31522249
2.

Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation.

Malavasi VL, Proietti M, Spagni S, Valenti AC, Battista A, Pettorelli D, Colella J, Vitolo M, Lip GY, Boriani G.

Am J Cardiol. 2019 Aug 22. pii: S0002-9149(19)30945-2. doi: 10.1016/j.amjcard.2019.08.008. [Epub ahead of print]

PMID:
31521256
3.

Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation.

Spinthakis N, Gue Y, Farag M, Srinivasan M, Wellsted D, Arachchillage DRJ, Lip GYH, Gorog DA.

Europace. 2019 Sep 1;21(9):1297-1306. doi: 10.1093/europace/euz176.

PMID:
31505618
4.

Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry.

Kornej J, Schumacher K, Sommer P, Potpara T, Arya A, Dagres N, Bollmann A, Husser-Bollmann D, Lip GYH, Hindricks G.

Europace. 2019 Aug 22. pii: euz233. doi: 10.1093/europace/euz233. [Epub ahead of print]

PMID:
31504447
5.

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.

Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, Fauchier L, Betts TR, Lewalter T, Saw J, Tzikas A, Sternik L, Nietlispach F, Berti S, Sievert H, Bertog S, Meier B; ESC Scientific Document Group .

Europace. 2019 Aug 31. pii: euz258. doi: 10.1093/europace/euz258. [Epub ahead of print] No abstract available.

PMID:
31504441
6.

Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?

Kozieł M, Lip GYH.

Eur Heart J. 2019 Sep 1. pii: ehz517. doi: 10.1093/eurheartj/ehz517. [Epub ahead of print] No abstract available.

PMID:
31504403
7.

Association between Epicardial Adipose Tissue and Embolic Stroke after Catheter Ablation of Atrial Fibrillation.

Ahn J, Shin SY, Shim J, Kim YH, Han SJ, Choi EK, Oh S, Shin JY, Choe JC, Park JS, Lee HW, Oh JH, Choi JH, Lee HC, Cha KS, Hong TJ, Lip GYH, Lim HE.

J Cardiovasc Electrophysiol. 2019 Sep 9. doi: 10.1111/jce.14154. [Epub ahead of print]

PMID:
31502330
8.

The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal.

Esteve-Pastor MA, Roldán V, Rivera-Caravaca JM, Ramírez-Macías I, Lip GYH, Marín F.

Thromb Haemost. 2019 Sep 9. doi: 10.1055/s-0039-1696955. [Epub ahead of print]

PMID:
31499565
9.

Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?: JACC Review Topic of the Week.

Gorog DA, Lip GYH.

J Am Coll Cardiol. 2019 Sep 10;74(10):1366-1375. doi: 10.1016/j.jacc.2019.07.030. Review.

PMID:
31488274
10.

Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry).

An Y, Ogawa H, Esato M, Ishii M, Iguchi M, Masunaga N, Aono Y, Ikeda S, Doi K, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M; Fushimi AF Registry Investigators.

Am J Cardiol. 2019 Aug 7. pii: S0002-9149(19)30879-3. doi: 10.1016/j.amjcard.2019.07.048. [Epub ahead of print]

PMID:
31488250
11.

Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.

Guo Y, Wang H, Zhang H, Liu T, Liang Z, Xia Y, Yan L, Xing Y, Shi H, Li S, Liu Y, Liu F, Feng M, Chen Y, Lip GYH; MAFA II investigators.

J Am Coll Cardiol. 2019 Aug 22. pii: S0735-1097(19)36365-X. doi: 10.1016/j.jacc.2019.08.019. [Epub ahead of print]

PMID:
31487545
12.

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.

Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, Fauchier L, Betts TR, Lewalter T, Saw J, Tzikas A, Sternik L, Nietlispach F, Berti S, Sievert H, Bertog S, Meier B.

EuroIntervention. 2019 Aug 31. pii: EIJY19M08_01. doi: 10.4244/EIJY19M08_01. [Epub ahead of print] No abstract available.

13.

Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement.

Kozieł M, Lip GYH.

Lancet Haematol. 2019 Aug 20. pii: S2352-3026(19)30164-4. doi: 10.1016/S2352-3026(19)30164-4. [Epub ahead of print] No abstract available.

PMID:
31444125
14.

Atrial Fibrillation in Older People: Concepts and Controversies.

Zathar Z, Karunatilleke A, Fawzy AM, Lip GYH.

Front Med (Lausanne). 2019 Aug 8;6:175. doi: 10.3389/fmed.2019.00175. eCollection 2019. Review.

15.

Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.

Hohnloser SH, Steg PG, Oldgren J, Nickenig G, Kiss RG, Ongen Z, Navarro Estrada JL, Oude Ophuis T, Lip GYH, Nordaby M, Kleine E, Ten Berg JM, Bhatt DL, Cannon CP; RE-DUAL PCI Steering Committee and Investigators.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1553-1561. doi: 10.1016/j.jcin.2019.05.050.

PMID:
31439336
16.

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.

Merino JL, Lip GYH, Heidbuchel H, Cohen AA, De Caterina R, de Groot JR, Ezekowitz MD, Le Heuzey JY, Themistoclakis S, Jin J, Melino M, Winters SM, Merkely B, Goette A.

Europace. 2019 Aug 22. pii: euz213. doi: 10.1093/europace/euz213. [Epub ahead of print]

PMID:
31436835
17.

Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better?

Ding WY, Potpara TS, Stables RH, Lip GYH.

J Cardiovasc Electrophysiol. 2019 Aug 20. doi: 10.1111/jce.14130. [Epub ahead of print] No abstract available.

PMID:
31432597
18.

Neurovascular coupling and cerebral autoregulation in atrial fibrillation.

Junejo RT, Braz ID, Lucas SJ, van Lieshout JJ, Phillips AA, Lip GY, Fisher JP.

J Cereb Blood Flow Metab. 2019 Aug 19:271678X19870770. doi: 10.1177/0271678X19870770. [Epub ahead of print]

PMID:
31426699
19.

Integrated care for the management of atrial fibrillation: what are the key components and important outcomes?

Lane DA, Lip GYH.

Europace. 2019 Aug 7. pii: euz211. doi: 10.1093/europace/euz211. [Epub ahead of print] No abstract available.

PMID:
31390468
20.

Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.

Lau WCY, Douglas IJ, Wong ICK, Smeeth L, Lip GYH, Leung WK, Siu CW, Cheung BMY, Mok MTC, Chan EW.

Heart Rhythm. 2019 Aug 1. pii: S1547-5271(19)30720-9. doi: 10.1016/j.hrthm.2019.07.034. [Epub ahead of print]

PMID:
31377423
21.

Clinical factors and imaging leading to risk of incident atrial fibrillation.

Shantsila A, Oxborough D, Fairbairn TA, Lip GYH.

Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):988-989. doi: 10.1093/ehjci/jez199. No abstract available.

PMID:
31356655
22.

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA).

Kalarus Z, Svendsen JH, Capodanno D, Dan GA, De Maria E, Gorenek B, Jędrzejczyk-Patej E, Mazurek M, Podolecki T, Sticherling C, Tfelt-Hansen J, Traykov V, Lip GYH, Fauchier L, Boriani G, Mansourati J, Blomström-Lundqvist C, Mairesse GH, Rubboli A, Deneke T, Dagres N, Steen T, Ahrens I, Kunadian V, Berti S.

Europace. 2019 Jul 29. pii: euz163. doi: 10.1093/europace/euz163. [Epub ahead of print]

PMID:
31353412
23.

Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile.

Charantharayil Gopalan B, Namboodiri N, Abdullakutty J, Lip GY, Koshy AG, Krishnan Nair V, Babu S, Muhammed S, Azariah JL, George R, Nambiar A, Govindan U, Zachariah G, Kumaraswamy N, Chakanalil Govindan S, Natesan S, Roby A, Velayudhan Nair K, Pillai AM, Daniel R; Kerala AF Registry Investigators.

BMJ Open. 2019 Jul 27;9(7):e025901. doi: 10.1136/bmjopen-2018-025901.

24.

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.

Wilson D, Ambler G, Shakeshaft C, Banerjee G, Charidimou A, Seiffge D, White M, Cohen H, Yousry T, Salman R, Lip GYH, Muir K, Brown MM, Jäger HR, Werring DJ; CROMIS-2 collaborators.

BMJ Open. 2019 Jul 24;9(7):e028387. doi: 10.1136/bmjopen-2018-028387.

25.

Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding.

Kozieł M, Ding WY, Kalarus Z, Lip GYH.

Expert Rev Hematol. 2019 Jul 26:1-11. doi: 10.1080/17474086.2019.1647779. [Epub ahead of print]

PMID:
31334670
26.

Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.

Lee SR, Rhee TM, Kang DY, Choi EK, Oh S, Lip GYH.

Am J Cardiol. 2019 Sep 15;124(6):879-885. doi: 10.1016/j.amjcard.2019.05.072. Epub 2019 Jun 25.

PMID:
31311662
27.

Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation.

Cheng WH, Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Lip GYH, Chen SA.

Stroke. 2019 Sep;50(9):2574-2577. doi: 10.1161/STROKEAHA.119.025623. Epub 2019 Jul 10.

PMID:
31288672
28.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ.

J Am Coll Cardiol. 2019 Jul 9;74(1):83-99. doi: 10.1016/j.jacc.2019.05.016. Review.

PMID:
31272556
29.

Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study.

Yoon M, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, Kim JY, Sung JH, Pak HN, Lee MH, Joung B, Lip GYH.

Thromb Haemost. 2019 Jul 2. doi: 10.1055/s-0039-1693516. [Epub ahead of print]

PMID:
31266082
30.

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey.

Lane DA, Meyerhoff J, Rohner U, Lip GYH.

TH Open. 2018 Jul 5;2(3):e233-e241. doi: 10.1055/s-0038-1666803. eCollection 2018 Jul.

31.

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.

Lee SR, Lee HJ, Choi EK, Han KD, Jung JH, Cha MJ, Oh S, Lip GYH.

J Am Coll Cardiol. 2019 Jul 2;73(25):3295-3308. doi: 10.1016/j.jacc.2019.04.052.

PMID:
31248551
32.

C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.

Li YG, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B, Wang YT, Lip GYH, Fauchier L.

J Am Heart Assoc. 2019 Jul 2;8(13):e012546. doi: 10.1161/JAHA.119.012546. Epub 2019 Jun 25.

33.

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry.

Liang HF, Du X, Zhou YC, Yang XY, Xia SJ, Dong JZ, Lip GYH, Ma CS.

Med Sci Monit. 2019 Jun 24;25:4691-4698.

34.

Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke.

Kozieł M, Potpara TS, Lip GYH.

Stroke. 2019 Aug;50(8):1956-1957. doi: 10.1161/STROKEAHA.119.026185. Epub 2019 Jun 20. No abstract available.

PMID:
31216960
35.

Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.

Kim D, Yang PS, Yu HT, Kim TH, Jang E, Sung JH, Pak HN, Lee MY, Lee MH, Lip GYH, Joung B.

Eur Heart J. 2019 Jul 21;40(28):2313-2323. doi: 10.1093/eurheartj/ehz386.

PMID:
31212315
36.

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.

Lee SR, Choi EK, Kwon S, Han KD, Jung JH, Cha MJ, Oh S, Lip GYH.

Stroke. 2019 Aug;50(8):2245-2249. doi: 10.1161/STROKEAHA.119.025536. Epub 2019 Jun 18.

PMID:
31208303
37.

β-Blocker Use in Pregnancy and the Risk for Congenital Malformations.

Shantsila A, Beevers DG, Lip GYH.

Ann Intern Med. 2019 Jun 18;170(12):909. doi: 10.7326/L19-0156. No abstract available.

PMID:
31207629
38.

Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial".

Guo Y, Lip GYH, Potpara T.

Circulation. 2019 Jun 11;139(24):e1037-e1038. doi: 10.1161/CIRCULATIONAHA.118.038961. Epub 2019 Jun 10. No abstract available.

PMID:
31180748
39.

Response.

Lip GYH, Ruff CT, Moores L; 2018 CHEST Guideline Expert Panel.

Chest. 2019 Jun;155(6):1311-1312. doi: 10.1016/j.chest.2019.03.037. No abstract available.

PMID:
31174653
40.

Response.

Lip GYH, Ruff CT, Moores L; 2018 CHEST Guideline Expert Panel.

Chest. 2019 Jun;155(6):1309. doi: 10.1016/j.chest.2019.03.001. No abstract available.

PMID:
31174651
41.

Response.

Lip GYH, Ruff CT, Moores L; 2018 CHEST guideline Expert Panel.

Chest. 2019 Jun;155(6):1307. doi: 10.1016/j.chest.2019.02.329. No abstract available.

PMID:
31174649
42.

Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices.

Pastori D, Miyazawa K, Li Y, Székely O, Shahid F, Farcomeni A, Lip GYH.

Clin Res Cardiol. 2019 May 29. doi: 10.1007/s00392-019-01493-z. [Epub ahead of print]

PMID:
31144064
43.

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.

Søgaard M, Skjøth F, Jensen M, Kjældgaard JN, Lip GYH, Larsen TB, Nielsen PB.

J Am Heart Assoc. 2019 Jun 4;8(11):e011358. doi: 10.1161/JAHA.118.011358. Epub 2019 May 29.

44.

Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.

Deng H, Shantsila A, Xue Y, Bai Y, Guo P, Potpara TS, Zhan X, Fang X, Liao H, Wu S, Lip GYH.

Arch Cardiovasc Dis. 2019 Jun - Jul;112(6-7):420-429. doi: 10.1016/j.acvd.2019.02.006. Epub 2019 May 25.

PMID:
31133543
45.

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism.

Zeng J, Zhang X, Lip GYH, Shu X, Thabane L, Tian J, Li G.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853629. doi: 10.1177/1076029619853629.

46.

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network.

Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23. Erratum in: Lancet Neurol. 2019 Sep;18(9):e8.

47.

Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2.

Panchal G, Mahmood M, Lip GYH.

Kardiol Pol. 2019 May 24;77(5):515-524. doi: 10.33963/KP.14846. Epub 2019 May 24.

48.

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.

Deitelzweig S, Keshishian A, Li X, Kang A, Dhamane AD, Luo X, Balachander N, Rosenblatt L, Mardekian J, Pan X, Nadkarni A, Di Fusco M, Garcia Reeves AB, Yuce H, Lip GYH.

J Am Geriatr Soc. 2019 Aug;67(8):1662-1671. doi: 10.1111/jgs.15956. Epub 2019 May 21.

PMID:
31112292
49.

Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.

Chan YH, Lee HF, See LC, Tu HT, Chao TF, Yeh YH, Wu LS, Kuo CT, Chang SH, Lip GYH.

Chest. 2019 Sep;156(3):529-543. doi: 10.1016/j.chest.2019.04.108. Epub 2019 May 16.

PMID:
31103697
50.

CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension.

Shantsila A, Lip GYH, Beevers DG.

J Hum Hypertens. 2019 May 14. doi: 10.1038/s41371-019-0209-8. [Epub ahead of print] No abstract available.

PMID:
31089198

Supplemental Content

Support Center